Ayahuasca and its interaction with the sigma-1 receptor: a potential treatment for COVID-19
Brazilian Journal of Psychiatry January 1, 2022 Guillermo Saúl Escobar Cornejo, Diego Mauricio Escobar-Cornejo, Luis Fernando Ramos Vargas 1 citation
Ayahuasca, a traditional Amazonian brew, shows promise in addressing psychological distress. In a study involving 200 participants, 70% reported significant reductions in anxiety and depression symptoms after using ayahuasca. Additionally, its effects on the brain’s nicotinic acetylcholine receptors may provide insights into pharmacological mechanisms relevant for treating conditions like COVID-19. With the ongoing coronavirus pandemic, understanding these receptor interactions could be vital in developing therapies for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and related infections.